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shorl-lived C (11/2 --20min)-labeled carboxylic acids for
Dosilron emission lomograp@ (PET) has been developed.
h’fieclable sol,lions off[l-’lC]acelic acid, [_/_11C]06,tal./Oi8 asid
and [1-11C]palmitic acid wilh radioactivities of @36-8"29 GBq,
0"070-1"43 (;Bq and 0"42-0"89 GBq were oblained. The
preparalion lime was under 40 rain aider lhe end of bombardmenl.
An aulomalic washing hnction means lhal labeled compoundf oj"
lhe same or dffkrenl kind can be produced several limes a @
e,ilhoul ar mainlenance qf lhe .slem. The conlrol ,slem is siled
az,q?,,/iom lhe ’hol laboralo’, so @eralor exposure Io radialion
is mirzimized.
radiation shielded room (hot laboratory). The computer
and its peripherals are in a separate room. The synthesis
system consists of a series of units which supply reagents,
perfbrm reactions, separate and purif) C-labeled
carboxylic acid, and formulate an injectable solution of
the lC-labeled carboxylic acid. The operation of" these
units is performed either automatically by the control
system or manually through the auto-manual switch box
(manual operation is usefhl fbr cold experiments and
maintenance). As the solenoid valves and other devices,
fbr example the reagent supply unit and reaction unit,
are set on a punched metal board, modification and
maintenance of the hardware is simple.
Synthesis apparatus
A diagram of the apparatus is shown in figure 1.
Introduction
Positron emission tomography (PET) is a non-invasive
diagnostic imaging technique in which short-lived radio-
active tracers are used to measure the anatomical
distribution and kinetics of in vivo biochemical processes
[1]. [1-C]Labeled carboxylic acids are useful radio-
tracers in PET studies; [1-C]labeled acetate and
palmitate have been used extensively as tracers tbr
monitoring cardiovascular fianctions [2-4]. Although a
number of" semi- or fully-automated systems fbr the
production of lC-labeled carboxylic acids have been
developed [5-11], they have drawbacks in that they
need manual washing befbre re-use and/or require the
attendance of specialist operators. Thus, a reliable system,
which would reproducibly deliver radiopharmaceuticals
on a routine and repetitive basis, is required.
’l’he design and construction of a fully automated
apparatus fbr producing [1-11C]labeled carboxylic acids
is described in this paper. The apparatus has been applied
to the repetitive production of [1-11C] acetic acid,
[- 1-1 C]octanoic acid and [ -
C]palmitic acid.
Automated synthesis apparatus of [1-C]labeled
carboxylic acid
ltardware
The automated apparatus consists of a synthesis system
and a control system. The synthesis system, an auto-
manual switch box, and I/O boards are placed in a
Reagent supply unils
The reagent supply unit has seven reservoirs (1-7
in figure 1) tbr reagent solutions and solvents. Each solu-
tion or solvent in the reservoirs is stored under argon
atmosphere, and can be transferred to the flasks (8-11 in
figure 1) in one or two steps. In the latter case, the liquid
is allowed to flow fiom the reservoir into a volumetric
tube by argon gas pressure. When a photosensor (31-37
in figure 1) on the tube detects the liquid, the valve at
the lower end of the reservoir is switched to stop the flow
of the liquid. The contents of the tube are transferred into
the reaction flask by argon gas pressure. By the use of
this volumetric device, the same volume of liquid may be
repeatedly measured out and added to the flask; even
moisture- or air-sensitive liquids can be handled. After a
synthetic run, all of the main flow lines and the flasks (8,
9 and 13 in figure 1) can be washed by passing a washing
solvent stored in reservoir 4, and then dried with dry
nitrogen. In this way radiopharmaceuticals of the same
or different kind can be produced during a day without
interruption due to maintenance.
Reaction unit
The reaction unit has two flasks (8 and 9 in figure 1).
Flask (8 in figure 1) carries out the Grignard coupling,
and is placed in a dry box (45 in figure 1) to keep off any
moisture. Flask 2 (9 in figure 1) quenches the reaction
and evaporates the solvent. Both flasks are about
2 ml in volume and have jackets through which the
heating/cooling fluid is circulated under temperature
control by a thermostat (23 in figure 1). The mixing of"
the reaction mixture in flask is accomplished by bubbling
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Figure 1. Diagram of the synthesis system: V1 V45 solenoid valve 1 45; 1 7 reservoir 1 7; 8 11 =flask 1 4;
12 vial; 13 degas flask; 14 and 15 tank 1 2 of HPLC; 16 HPLC pump; 17 rotary six-way valve; 18 sample loop;
19 HPLC column; 20 UV detector; 21 and 22 radiation detector 1 and 2; 23 thermostat; 24 drainage lank; 25 vacuum
pump; 26 28 magnetic stirrer; 29 pH sensor; 30 level sensor; 31 38 photosensor 1 8; 39 and 40 sodalime 1 and 2;
41 and 42 =filter 1 and 2; 43 and 44 mass flow controller 1 and 2; 45 dry box; 46 and 47 argon gas line; 48 11COe gas
line; 49 waste gas line.
argon gas. The bubbling rate is controlled with a mass
flow controller (43 in figure ). The mixing of the reaction
mixture in flask 2 is accomplished by a magnetic
stirrer (26 in figure 1), and the evaporation in flask 2 is
carried out under vacuum created by the vacuum device
(25 and 40 in figure 1). Transfer of the reaction mixture
in flask to flask 2, or the solution in flask 2 to the
purification unit, is carried out by the use of argon gas
pressure.
Purification unit
The purification unit is composed of two systems: a
degassor system which also serves as a part of an injecting
system into the high performance liquid chromatography
(HPLC) column and an HPLC system. The degassor
system consists of a degassing flask (13 in figure 1; about
2 ml in volume), a photosensor (38 in figure 1), a rotary
six-way valve (17 in figure 1) and a sample loop (18 in
figure 1). The degassing flask has a jacket through which
a heating/cooling fluid is circulated. The HPLC system
consists of a pump (16 in figure 1), an HPLC column (19
in figure 1), a UV detector (20 in figure 1) and a radiation
detector (22 in figure 1). The concentrate obtained in
flask 2 is transtirred to the degassing flask, degassed and
then sent to the sample loop of an HPLC apparatus,
through the photosensor (38) and a rotary six-way valve.
When the photosensor (38) detects the end of the solution,
the rotary six-way valve rotates its position automatically
and the mixture in the sample loop is then loaded to the
HPLC column by the HPLC pump (16). The fraction
which contains the product is detected by the radiation
detector (22) and collected in a flask (10 in figure 1).
Pharmacological formulation unit
The pharmacological formulation unit has two flasks (10
and 11 in figure 1) and one vial. Flask 3 (10 in figure 1)
has a jacket which is thermostated by circulating the
heating/cooling fluid through it. The contents of flask 3
are concentrated under reduced pressure stirred with a
magnetic stirrer (27 in figure 1) and heated in order to
remove any organic solvent. The residual solution in
flask 3 is transferred to flask 4 (11 in figure 1), which is
equipped with a magnetic stirrer (28 in figure 1), a pH
sensor (29 in figure 1) a.nd a level sensor (30 in figure 1).
The pH and volume of the solution can be adjusted in
flask 4 to the desired values by adding an alkaline solution,
an albumin solution or saline. The resultant solution is
filtered through a 0.22 gm membrane filter (41 in
figure 1) into a product vial (12 in figure 1) to give a
solution ofa 11C-labeled compound in a ready-to-use form
for a PET study after an appropriate quality assurance
procedure.
Control system
Computer and interface hardware
The apparatus is controlled with a personal computer
(PC-9821Ap, NEC); an adaptor (RS422) in the computer
controls I/O boards, Optomux (Opto22, USA). Six
Optomux digital and two analogue brain boards, each
with 16 I/O channels, are used. Each board has a unique
address to help identify every device in the system, for
example five digital output boards give 80 switches for
operating valves and relays. One digital input board reads
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the status of 16 indicator lamps that are used for
monitoring photosensors, the level sensor, and the position
of the rotary six-way valve. The analogue boards are for
reading status information from the system, including
radioactivity, pH, UV absorbance, the rates of the mass
flow controllers and pressure, and for writing information
to set rates of the mass flow controllers.
Soflware
The software was developed with a development program
called ’Hyakuninriki’ (Asahi Electronics Co. Ltd, Japan),
which operates under MS-DOS. The software has
functions tbr control logic and graphic displays. The
program consists of a series of connected control blocks
with the flow depending on the control logic sequence.
More than 140 control blocks of 16 different types are
used and each block is programmed to perform a function,
to flask2
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Figure 2. Flowchart of the total operation: The preparation of
the apparatus process contains subroutines of’Check rotary valve’
and ’Preparation’. The Grignard reaction process contains
subroutinesfrom ’Add Grignard’ to ’Add solvent’. Thepurification
process contains subroutines from’Inject to HPLC’ to ’Transfer
toflask 4’. Theformulation process contains subroutines of’Adjust
pH in flask 4’, ’Adjust level in flask 4’ and’Transfer to vial’
and the washing process contains subroutines from ’Wash flask 1
with THF’ to ’Waste out’.
such as controlling a switching sequence or reading the
status of sensors. The program consists of five processes,
for example preparation of the apparatus, Grignard
reaction, purification, formulation and washing processes
(see figure 2). The preparation of the apparatus process is
controlled by the method of close loop and a time
sequential method. The Grignard reaction process and
the purification process are performed by sequential
control using a signal from the photosensor and a time
sequential method. The formulation process is controlled
by the method of close loop, and the washing process is
controlled by the method of close loop, sequential control
using the signal of photosensors and a time sequential
method.
Operating procedure
Layout of the hot experiment zone
The layout of the hot-experiment zone is shown in
figure 3; the four rooms used (cyclotron room, hot
laboratory, pass room and control room) are isolated from
each other. The values of the radioisotope calibrators can
be monitored with two video cameras in the control room.
Preparation for synthesis
The reservoirs (1-7 in figure 1) of the apparatus are filled
as follows: reservoir 1-3 (0"2M solution of Grignard
reagents in anhydrous THF), reservoir 4 (anhydrous
THF), reservoir 5 (a mixture of 1N HC1 and the eluent
for HPLC 1:1 (v/v)), reservoir 6 (7 NaHCO3 solution
in the case of acetic and octanoic acid or an albumin
solution in the case of palmitic acid), reservoir 7 (saline).
The HPLC system is turned on. The temperature of the
fluid in the jacket is set and the position of the rotary
six-way valve is set to the correct starting position. Argon
gas flow rates of the mass flow controllers and 2 are set
to 50 ml/min. The degassing system is purged with argon
gas (flow line: 46-43-V43-V27-13-38-17-18-V28 in figure
1) for 15 min, and then flask is purged with argon gas
(flow line: 46-43-V 1-V3-31-8-V25-V26-39-49 in figure 1)
by switching V1 and V3.
Reaction of 11C02 with Grignard reagents
Production of 11COz is accomplished via 14N(p, )axC
reaction by proton bombardment (18 MeV, 15 gA) on
N2 gas target (14.7kg/cm2) using a cyclotron-target
system (CYPRIS HM-18, Sumitomo Heavy Industries
Co. Ltd, in figure 2). After irradiation, the XCOz-
containing target gas is transferred to a CO2 trap
(AMCT 01, NKK Corp. in figure 2). [11C] Carbon
dioxide is trapped in a coiled tube dipped into liquid
argon. Then, the trapped lXCO2 is transferred to the
synthesis apparatus with heating the coil and by the flow
of He gas (20 ml/min). The radioisotope detector on the
inlet line (CsI scintillator (gas in) in figure 2) is used to
monitor the release of radioactivity from the trap. The
outlet of reservoir (1, 2 or 3 in figure 1) is opened by
switching valves (V2 and V3, V5 and V6, or V8 and V9 in
figure 1) to measure the Grignard solution. And the
measured solution is transferred into flask 1. This
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Figure 3. Layoul jbr hol experimenls.
operation is repeated three times immediately after the
release of radioactivity. Valves V42, V23, V25 and V26
are then switched to direct the flow of 11CO2 gas to
flask 1. The 11CO2 gas is bubbled through the Grignard
solution tbr 2 min 30 sec; a sodalime trap (39 in figure 1)
prevents any radioactive gas from leakage. Then, the
reaction mixture in flask is transferred to flask 2 by
switching valves V42, V23, V25, V26, V1, V3, V24 and
V29 (flow line: 46-43-V1-V3-8-V24-V22-9-V29). Flask
is rinsed once with 1’0 ml of THF from reservoir 4 and
the washings are also transferred to flask 2.
Quenching and evaporalion
The power switches of the vacuum pump and the
magnetic stirrer (26 in figure 1) are turned on. Then
valves V30 and V40 are switched, and the reaction
mixture is concentrated under reduced pressure. After
evaporation, the vacuum pump is stopped, and in order
to break the vacuum, valve V29 is ;witched. The residue
in flask 2 is dissolved in 2"0 ml of a solution from
reservoir 5 in a similar manner (flow line: 46-43-5-V15-
35-9-V29) as above.
Purijicalion andformulalion
The product of the previous step is purified and separated
via the degassor system and HPLC system as follows"
Valves V 13, V 15 and V27 are switched to deliver the
solution in flask 2, which may contain air bubbles,
to the degassing flask with argon gas pressure (flow
line: 46-43-V 13-V 15-35-9-13-V27).
(2) Valve V27 is switched, and the degassed solution is
sent to the sample loop via photosensor (38 in
figure 1) and the rotary six-way valve.
(3) When the end of the solution is detected by photo-
sensor (38 in figure 1), the rotary six-way valve is
switched and the solution in the sample loop is loaded
to the HPLC column.
(4) The eluate from the HPLC is monitored by the UV
and radiation detectors on the HPLC-eluate line and
the fraction containing [1-11C]carboxylic acid is
collected in flask 3 by switching valves V33 and V36.
A magnetic stirrer (27 in figure 1) is then started.
After the collection is finished, evaporation of.the
contents of flask 3 is performed by switching valves V37,
V40 and the vacuum pump. When the evaporation is
completed, the vacuum p.ump is stopped, and valve V36
is switched in order to release the vacuum. The residue
in flask 3 is dissolved in NaHCOa solution (2"0ml)
transferred from reservoir 6 (flow line: 46-43-V 17-6-V 18-
V39-10), and then the solution in flask 3 is transferred to
flask 4 by switching valves V16, V18, V39 and V28 (flow
line: 46-43-V16-V18-36-V39-10-V35-11-V38).
The magnetic stirrer 3 is switched on and the pH value
of the solution in flask 4 is measured with the pH sensor.
The pH value is adjusted, if necessary, to the range from
8"5 to 9"0 by the addition of the NaHCOa solution from
reservoir 6 and the resulting solution in flask 4 is then
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diluted with saline from reservoir 7 by adding it to the
solution until the level sensor, which is set beforehand to
a volume of 10 ml, is activated. Finally the product is
filtered through a 0"22 gm sterile filter by applying
argon gas pressure (flow line: 46-43-V19-V21-V34-V35-
Vll-41-12) into a sealed vial placed in a radioisotope
calibrator measuring the radioactivity of the final product
in passroom (figure 2). The product is then analysed by an
analytical HPLC to confirm the quality.
Table 2. Radioactivities of the successive
production of [1_11C] octanoic acid.
*Radioactivity
Run # (GBq)
1"22
2 0"70
*At the end of formulation.
Washing of the apparatus
Washing ofthe apparatus can be started immediately after
the final solution of the product has been obtained. The
position of the rotary six-way valve is set to the starting
position. The washing of flask is performed by sending
2"0 ml of anhydrous THF from reservoir 4 and the
washings are transferred to flask 2 in a similar manner as
above. These operations are repeated twice. The washing
solution in flask 2 is evaporated to dryness under reduced
pressure in a similar manner mentioned above. After
evaporation, flask 2 is washed with 2"0 ml of a solution
fiom reservoir 5. These operations are repeated twice.
Finally the washings are transferred to a waste tank out
of the apparatus by argon gas pressure (flow line:
46-43-V 13-V 15-35-9-13-38-17-V28).
apparatus, the apparatus can be used for repetitive
synthesis of other [1-11C]labeled carboxylic acids with
only minor changes on the software and hardware. Finally
the operator’s exposure to radiation is minimized.
Experimental
Materials and reagents
As Grignard reagents are very moisture sensitive, they
were injected into reservoir(s) 1, 2 and/or 3, capped with
a Teflon-lined septum and flushed with argon, before the
start of synthesis. Tetrahydrofuran (THF) was freshly
distilled over lithium aluminium hydride under argon
atmosphere just before use.
Results and discussion
With the apparatus described, injectable solutions of
[1-11C]labeled carboxylic acids with different chain
lengths, e.g. [1-11C]acetic acid, [1-11C]octanoic acid and
[1-11C]palmitic acid, were obtained. Table shows the
ranges of the radioactivities and radiochemical purity of
[ 1-11C]labeled carboxylic acids produced on several runs.
The total synthesis time from the end of bombardment
to the end of tbrmulation was within 40 min. lcoz was
produced via 14N(p, )11C reaction by proton bombard-
ment (18 MeV, 15 gA) on a 14"7 kg/cm
2 N2 gas target
for 40 min.
The apparatus washes automatically, so labeled com-
pounds of the same or different kinds can be produced
several times during a day without maintenance of the
system. Table 2 shows the result of repetitive synthesis of
[-1-11C]octanoic acid. [ 1-11C]octanoic acid was obtained
twice a day without maintenance of the apparatus.
Although [1-11C]octanoic acid has been selected and
synthesized repetitively to show the performance of the
Table 1. Radioactivities of the [1-11C-] labeled carboxylic acids.
*Radioactivity Radiochemical
Compounds (GBq) purity ()
[1-11C]acetic acid 6-36-8"29 > 99
[1-11C]octanoic acid 0"70-1"43 > 99
[1-11C]palmitic acid 0"42-0"89 > 99
*At the end of tbrmulation.
Production of [1-11 C] acetic acid
The reservoirs of the apparatus were filled as follows
(the quantities in parentheses are those used for one
synthesis)--reservoir 1:0"2 M CH3MgBr/THF (0"5 ml),
reservoir 4: THF (1"0 ml), reservoir 5: a mixture of 1N
HC1 and 0.025 M NaC1 (1:1 (v/v)) (0"5 ml), reservoir 6:
7 NaHCO3aq. (2"0 ml), reservoir 7: saline (5"0 ml). The
fluid in the thermostat (23 in figure 1) was cooled to the
temperature of-26C, and valves V44 and V45 were
switched in order to cool flask only. The HPLC
conditions used were for preparation, column: Waters
protein pack G-QA 20 I.D.*100mm, eluent: 0"025M
NaC1, flow rate: 5"0 ml/min, detector (UV): 214 nm,
temperature: room temperature, retention time: c. 11 min
and radiodetector: Aloka Positron Monitor TCS-R81-
3454 and for analysis, column: YMC-Pack ODS-AQ,
AQ-303 4"6 I.D.*250mm, eluent: 20mM H3PO4-
NaH2PO4 (pH2"8), flow rate: 0"7 ml/min, detector (UV):
214 nm, temperature: room temperature, retention time:
c. 8"5 min, and radiodetector: Aloka Gamma Detector
FGD- 102 and Radio Analyser RLC700.
Production of [1-11C] octanoic acid
The reservoirs of the apparatus were filled as follows,
(the quantities in parentheses are those used in one
synthesis)-reservoir 2: 0"2M CTH15MgBr/THF (0"5 ml),
reservoir 4: THF (l’0ml), reservoir 5: a mixture of
1N HC1 and CH3CN:HzO:6N HCI= 1:1:0"002 (v/v)
(0"5 ml), reservoir 6: 7 NaHCO3aq. (2"0 ml), reservoir
7: saline (5"0 ml). The reaction was carried out at room
temperature. The HPLC conditions used were, for
preparation, column: YMC-ODS-AQ 10 I.D.’250 mm,
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eluent: CH3CN:H20:6 N HC1 1:1:0"002 (v/v), flow
rate: 5"0 ml/min, detector (UV): 214 nm, temperature
room temperature, retention time: c. 11 min, and radio-
detector: Aloka Positron Monitor TCS-R81-3454 and, for
analysis, column: YMC-ODS-AQ 4"6 I.D.*250mm,
eluent: CH3CN:H20:6N HC1 600:400:1 (v/v), flow
rate: 1"0 ml/min, detector (UV): 214 nm, temperature:
room temperature, retention time: c. 12 min, and radio-
detector: Aloka Gamma Detector FGD-102 and Radio
Analyser RLC-700.
Production of [l_11C]palmitic acid
The reservoirs of the apparatus were filled as follows, (the
quantities in parentheses are those used in one synthesis)-
reservoir 3:0"2 M C15H31MgBr/THF (0"5 ml), reservoir
4: THF (1"0 ml), reservoir 5: a mixture of 1N HC1 and
CH3CN:H20 95:7 (v/v) (0"5 ml), reservoir 6: Albumin
solution (2"0 ml), reservoir 7: saline (5"0 ml). The fluid in
the thermostat (23 in figure 1) was warmed to the
temperature of 56C, and the outlet of it was opened by
switching valve V45. Flask 1, 2 and the degas flask were
warmed to the same temperature. The HPLC conditions
used were, for preparation, column: YMC-ODS-AQ 10
I.D.’250 mm, .eluent: CH3CN:H20 95:7 (v/v), flow
rate: 5"0 ml/min, detector(UV): 214 nm, temperature:
room temperature, retention time: c. 12 min, and radio-
detector: Aloka POSITRON MONITOR TCS-RS1-
3454 and, tbr analysis, column: YMC-ODS-AQ 10
I.D.*250mm, eluent: CH3CN:H20 95:7 (v/v), flow
rate: 0"8 ml/min, detector (UV): 214 nm, temperature:
room temperature, retention time: c. 12 min, and radio-
detector: Aloka Gamma Detector FGD-102 and Radio
Analyser RLC-700.
Successive production of [1-11C] octanoic acids
All the conditions are the same as above for the production
of [1-lC]octanoic acid. The apparatus is washed
between sequential production of[ 1-1 C-] octanoic acids.
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